SCHEMBL20109609

SCHEMBL20109609

Cc1cc(N(c2ccccc2)c2ccc3c(c2)sc2ccccc23)ccc1N(c1ccccc1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.37
▸ MAPT P10636 3/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ GPR3 P46089 1/20 0.35
▸ ABCB1 P08183 1/20 0.32
▸ LIMK1 P53667 1/20 0.32
▸ PTPN1 P18031 1/20 0.31
▸ TNKS2 Q9H2K2 2/20 0.31
▸ APP P05067 1/20 0.31
▸ TNKS O95271 1/20 0.31
▸ ACLY P53396 1/20 0.31
▸ L3MBTL1 Q9Y468 2/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ POLB P06746 1/20 0.30
▸ GAA P10253 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ ATM Q13315 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18199836 0.88 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL21966475 0.88 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL21282015 0.88 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL14295400 0.88 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL14295402 0.88 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL16356679 0.88 ALDH1A1 (0.46) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL20109612 0.88 GPR3 (0.33) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL20109611 0.88 F9 (0.36) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL24612813 0.87 ALDH1A1 (0.47) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2
SCHEMBL19167039 0.87 ALDH1A1 (0.47) ALDH1A1MAPTRAB9AHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2018-05-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180123048-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT COMPRISING THE SAME AND ELECTRONIC DEVICE THEREOF PIEZO1, OCIAD1, LEF1 ALDH1A1 493/4885MAPT 2943/4885RAB9A 3223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback